Showing results (71-80 of 980) with videos related to
Sort By:
Pageof 98
Cardiovascular Therapeutics|November 24, 2022
Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary SyndromeWanwen Kong, Junyi Ma, Ying Lin, et al.Cardiovascular Therapeutics|May 23, 2022
Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial HypertrophyXi Zheng, Fuxiang Su, Ze Kang, et al.Cardiovascular Therapeutics|July 22, 2021
Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant ResponsesXiaowen Shi, Bin Zhang, Zhenliang Chu, et al.Cardiovascular Therapeutics|December 29, 2017
Nicorandil for the prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trialsXiaofen Ma, Xiang Li, Zhanfeng Jiao, et al.Cardiovascular Therapeutics|May 25, 2023
Analysis of the Efficacy and Safety of Coronary Catheterization through Distal Transradial Access: A Single-Center DataHuanhuan Wang, Dan Liu, Jidong Guo, et al.Cardiovascular Therapeutics|April 28, 2023
Efficacy of Acupuncture in the Treatment of Essential Hypertension: An Overview of Systematic Reviews and Meta-AnalysesMaoxia Fan, Guohua Dai, Runmin Li, et al.Cardiovascular Therapeutics|July 5, 2018
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysisZhen Ge, Michela Faggioni, Usman Baber, et al.Cardiovascular Therapeutics|June 5, 2018
Lipid-lowering therapy with PCSK9-inhibitors in the real-world setting: Two-year experience of a regional lipid clinicBarak Zafrir, Ayman JubranCardiovascular Therapeutics|April 16, 2018
Effects of geranylgeranylacetone upon cardiovascular diseasesShengqiang Zeng, Hong Wang, Zaihua Chen, et al.Cardiovascular Therapeutics|September 1, 2016
Colchicine for prevention and treatment of cardiac diseases: A meta-analysisNikolaos Papageorgiou, Alexandros Briasoulis, George Lazaros, et al.Pageof 98